115450 — HLB Therapeutics Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for HLB Therapeutics Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	28,786	100,507	63,952	32,353	37,773
Net Total Accounts Receivable
Net Total Receivables	5,651	8,949	8,729	10,006	9,118
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	37,859	113,253	80,012	49,825	54,125
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9,162	9,781	15,780	10,068	9,530
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	121,938	189,711	187,643	200,795	219,793
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	18,335	56,717	58,628	26,791	31,904
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	32,585	71,032	70,936	40,329	62,329
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	89,354	118,679	116,708	160,466	157,465
Total Liabilities & Shareholders' Equity	121,938	189,711	187,643	200,795	219,793
Total Common Shares Outstanding